-
Founded in:
2002-03-29 -
Country:
China -
Address:
Tonghui Road, Processing, Warehousing and Logistics Park, Emeishan City -
Tax NO.:
91511181621167487U -
Registered Funds:
54.138461 yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ascorbic Acid |
It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell matrix, can reduce capillary permeability, accelerate blood coagulation, stimulate blood coagulation function, promote iron absorption in the intestine, promote blood lipid reduction, increase resistance to infection, participate in detoxification function, and has anti-histamine effect and prevents the formation of carcinogens (nitrosamines).
More
It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell matrix, can reduce capillary permeability, accelerate blood coagulation, stimulate blood coagulation function, promote iron absorption in the intestine, promote blood lipid reduction, increase resistance to infection, participate in detoxification function, and has anti-histamine effect and prevents the formation of carcinogens (nitrosamines). |
50-81-7 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ascorbic Acid |
It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell matrix, can reduce capillary permeability, accelerate blood coagulation, stimulate blood coagulation function, promote iron absorption in the intestine, promote blood lipid reduction, increase resistance to infection, participate in detoxification function, and has anti-histamine effect and prevents the formation of carcinogens (nitrosamines).
More
It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell matrix, can reduce capillary permeability, accelerate blood coagulation, stimulate blood coagulation function, promote iron absorption in the intestine, promote blood lipid reduction, increase resistance to infection, participate in detoxification function, and has anti-histamine effect and prevents the formation of carcinogens (nitrosamines). |
50-81-7 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Atinol |
It is a selective β1-adrenergic receptor blocker with no membrane stabilizing effect and endogenous sympathomimetic activity. However, it does not inhibit the bronchodilator effect of isoproterenol. Its mechanism of lowering blood pressure and reducing myocardial oxygen consumption is the same as that of propranolol. Large-scale clinical trials have confirmed that atenolol can reduce the mortality rate of acute myocardial infarction within 0 to 7 days. The therapeutic dose has no significant inhibition on myocardial contractility.
More
It is a selective β1-adrenergic receptor blocker with no membrane stabilizing effect and endogenous sympathomimetic activity. However, it does not inhibit the bronchodilator effect of isoproterenol. Its mechanism of lowering blood pressure and reducing myocardial oxygen consumption is the same as that of propranolol. Large-scale clinical trials have confirmed that atenolol can reduce the mortality rate of acute myocardial infarction within 0 to 7 days. The therapeutic dose has no significant inhibition on myocardial contractility. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 3-amino-1-hydroxypropylidene-1,1-diphosphonic acid disodium pentahydrate |
This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.
More
This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cytidine 5'-triphosphate disodium salt |
Cytidine triphosphate disodium is a coenzyme drug and a nucleotide derivative. It participates in the synthesis and metabolism of phospholipids and nucleic acids in the body. It is an intermediate product and energy source for brain phospholipid synthesis and nucleic acid metabolism.
More
Cytidine triphosphate disodium is a coenzyme drug and a nucleotide derivative. It participates in the synthesis and metabolism of phospholipids and nucleic acids in the body. It is an intermediate product and energy source for brain phospholipid synthesis and nucleic acid metabolism. |
36051-68-0 | 10 |